Samsung Biologics, Aprinoia Inks Deal to Develop Alzheimer’s Treatment
Samsung Biologics announced on Tuesday that it signed a contract with Aprinoia Therapeutics to develop the Taiwan-based biotech firm's Alzheimer's ...
Samsung Biologics announced on Tuesday that it signed a contract with Aprinoia Therapeutics to develop the Taiwan-based biotech firm's Alzheimer's ...
Copyright © 2022 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : [email protected] |
Copyright © 2022 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : [email protected] |